GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Royalty Pharma PLC (NAS:RPRX) » Definitions » Dividends per Share

Royalty Pharma (Royalty Pharma) Dividends per Share

: $0.80 (TTM As of Dec. 2023)
View and export this data going back to 2020. Start your Free Trial

Royalty Pharma's dividends per share for the three months ended in Dec. 2023 was $0.20. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.80. Its Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.24. As of today, Royalty Pharma's Dividend Yield % is 2.94%.

Good Sign:

Royalty Pharma PLC stock dividend yield is close to 5-year high.

During the past 12 months, Royalty Pharma's average Dividends Per Share Growth Rate was 5.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 38.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 7 years, the highest 3-Year average Dividends Per Share Growth Rate of Royalty Pharma was 38.70% per year. The lowest was 38.70% per year. And the median was 38.70% per year.

For more information regarding to dividend, please check our Dividend Page.


Royalty Pharma Dividends per Share Historical Data

The historical data trend for Royalty Pharma's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Royalty Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividends per Share
Premium Member Only Premium Member Only - 0.30 0.68 0.76 0.80

Royalty Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividends per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.20 0.20 0.20 0.20

Competitive Comparison

For the Biotechnology subindustry, Royalty Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Royalty Pharma Dividend Yield % Distribution

For the Biotechnology industry and Healthcare sector, Royalty Pharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Royalty Pharma's Dividend Yield % falls into.



Royalty Pharma Dividends per Share Calculation

Dividends paid to per common share.


Royalty Pharma  (NAS:RPRX) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Royalty Pharma's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0.2/ 0.826
=0.24

During the past 7 years, the highest Dividend Payout Ratio of Royalty Pharma was 0.55. The lowest was 0.33. And the median was 0.41.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Royalty Pharma Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.2102024-02-152024-02-162024-03-15Cash DividendquarterlyUSD:USD 1.000000
USD 0.2002023-11-162023-11-172023-12-15Cash DividendquarterlyUSD:USD 1.000000
USD 0.2002023-08-172023-08-182023-09-15Cash DividendquarterlyUSD:USD 1.000000
USD 0.2002023-05-182023-05-192023-06-15Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.


Royalty Pharma's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.81/27.615
=2.93 %

Current Share Price is $27.615.
Royalty Pharma's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.81.

During the past 7 years, the highest Dividend Yield of Royalty Pharma was 3.01%. The lowest was 0.31%. And the median was 1.74%.

Good Sign:

Royalty Pharma PLC stock dividend yield is close to 5-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Royalty Pharma Dividends per Share Related Terms

Thank you for viewing the detailed overview of Royalty Pharma's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Royalty Pharma (Royalty Pharma) Business Description

Traded in Other Exchanges
Address
110 East 59th Street, FL 33, New York, NY, USA, 10022
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Executives
Rory B Riggs director 65 RAILROAD AVE, RIDGEFIELD NJ 07657
Avara Management Ltd 10 percent owner C/O GISEV FAMILY OFFICE SA, CONTRADA DI SASSELLO 2, LUGANO V8 6900
Terrance P. Coyne officer: EVP & CFO C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK NY 10022
Pablo G. Legorreta director, officer: CEO, Chairman of the Board 110 E 59TH STREET, SUITE 3300, NEW YORK NY 10022
George W. Lloyd officer: EVP, Investments & GC C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK NY 10022
Marshall Urist officer: EVP, Research & Investments C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK NY 10022
Mario Germano Giuliani director, 10 percent owner C/O GISEV FAMILY OFFICE SA, CONTRADA DI SASSELLO 2, LUGANO V8 6900
James F. Reddoch officer: EVP, Research & Investments C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK NY 10022
Nogra Group Sicaf Sif Gg Strategic 10 percent owner C/O NOGRA GROUP SICAF-SIF S.A., 18 AVENUE DE LA PORTE NEUVE, LUXEMBOURG N4 L-2227
Nogra Group Sicaf - Sif S.a. 10 percent owner 18 AVENUE DE LA PORTE NEUVE, LUXEMBOURG N4 L-2227
Catherine M. Engelbert director 110 NORTH CARPENTER STREET, CHICAGO IL 60607
Errol B Desouza director 215 COLLEGE ROAD, PARAMUS NJ 07652
Henry A Fernandez director MSCI INC., 88 PINE STREET, NEW YORK NY 10005
Gregory Norden director 16640 CHESTERFIELD GROVE DRIVE, SUITE 200, CHESTERFIELD MO 63005
Ted W Love director C/O GLOBAL BLOOD THERAPEUTICS, INC., 400 EAST JAMIE COURT, SUITE 101, SOUTH SAN FRANCISCO CA 94080